A domain in TNF receptors that mediates ligand-independent receptor assembty and signaling

Science

Volumn 288, Issue 5475, 2000, Pages 2351-2354

  Chan, Francis Ka Ming ^a   Chun, Hyung J ^a   Zheng, Lixin ^a   Siegel, Richard M ^a   Bui, Kimmie L ^a,b   Lenardo, Michael J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; GENE FUNCTION; HUMAN; HUMAN CELL; LIGAND BINDING; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

AMINO ACID SUBSTITUTION; ANTIGENS, CD; APOPTOSIS; BINDING SITES; CROSS-LINKING REAGENTS; DIMERIZATION; ENERGY TRANSFER; FLUORESCENCE; HUMANS; LIGANDS; MACROMOLECULAR SUBSTANCES; MUTATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SUCCINIMIDES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034733682     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.288.5475.2351     Document Type: Article

References (56)

1. K. J. Tracey and A. Cerami, Annu. Rev. Cell Biol. 9, 317 (1993); Annu. Rev. Med. 45, 491 (1994).
2. K. J. Tracey and A. Cerami, Annu. Rev. Cell Biol. 9, 317 (1993); Annu. Rev. Med. 45, 491 (1994).
3. H. Wajant, K. Pfeffer, K. Pfizenmaier, P. Scheurich, Cytokine Growth Factor Rev.9, 297 (1998); A. Ashkenazi and V. M. Dixit, Science 281, 1305 (1998); G. G. Klaus et al., Int. Rev. Immunol. 15, 5 (1997); R. Horie and T. Watanabe, Semin., Immunol. 10, 457 (1998).
4. H. Wajant, K. Pfeffer, K. Pfizenmaier, P. Scheurich, Cytokine Growth Factor Rev.9, 297 (1998); A. Ashkenazi and V. M. Dixit, Science 281, 1305 (1998); G. G. Klaus et al., Int. Rev. Immunol. 15, 5 (1997); R. Horie and T. Watanabe, Semin., Immunol. 10, 457 (1998).
5. H. Wajant, K. Pfeffer, K. Pfizenmaier, P. Scheurich, Cytokine Growth Factor Rev.9, 297 (1998); A. Ashkenazi and V. M. Dixit, Science 281, 1305 (1998); G. G. Klaus et al., Int. Rev. Immunol. 15, 5 (1997); R. Horie and T. Watanabe, Semin., Immunol. 10, 457 (1998).
6. H. Wajant, K. Pfeffer, K. Pfizenmaier, P. Scheurich, Cytokine Growth Factor Rev.9, 297 (1998); A. Ashkenazi and V. M. Dixit, Science 281, 1305 (1998); G. G. Klaus et al., Int. Rev. Immunol. 15, 5 (1997); R. Horie and T. Watanabe, Semin., Immunol. 10, 457 (1998).
7. M. Lenardo et al., Annu. Rev. Immunol. 17, 221 (1999); D. Wallach et al., Annu. Rev. Immunol. 17, 331 (1999); A. M. Chinnaiyan et al., Cell 81, 505 (1995); M. P. Boldin et al. J. Biol. Chem. 270, 7795 (1995); M. Muzio et al., Cell 85, 817 (1996); M. P. Boldin et al., Cell 85, 805 (1996); H. Hsu et al., Immunity 4, 387 (1996); H. Shu, M. Takeuchi, D. V. Goeddel, Proc. Natl. Acad. Sci. U.S.A. 93, 13973 (1996); A. T. Ting, F. X. Pimentel-Muinos, B. Seed, EMBO J. 15, 6189 (1996).
8. M. Lenardo et al., Annu. Rev. Immunol. 17, 221 (1999); D. Wallach et al., Annu. Rev. Immunol. 17, 331 (1999); A. M. Chinnaiyan et al., Cell 81, 505 (1995); M. P. Boldin et al. J. Biol. Chem. 270, 7795 (1995); M. Muzio et al., Cell 85, 817 (1996); M. P. Boldin et al., Cell 85, 805 (1996); H. Hsu et al., Immunity 4, 387 (1996); H. Shu, M. Takeuchi, D. V. Goeddel, Proc. Natl. Acad. Sci. U.S.A. 93, 13973 (1996); A. T. Ting, F. X. Pimentel-Muinos, B. Seed, EMBO J. 15, 6189 (1996).
9. M. Lenardo et al., Annu. Rev. Immunol. 17, 221 (1999); D. Wallach et al., Annu. Rev. Immunol. 17, 331 (1999); A. M. Chinnaiyan et al., Cell 81, 505 (1995); M. P. Boldin et al. J. Biol. Chem. 270, 7795 (1995); M. Muzio et al., Cell 85, 817 (1996); M. P. Boldin et al., Cell 85, 805 (1996); H. Hsu et al., Immunity 4, 387 (1996); H. Shu, M. Takeuchi, D. V. Goeddel, Proc. Natl. Acad. Sci. U.S.A. 93, 13973 (1996); A. T. Ting, F. X. Pimentel-Muinos, B. Seed, EMBO J. 15, 6189 (1996).
10. M. Lenardo et al., Annu. Rev. Immunol. 17, 221 (1999); D. Wallach et al., Annu. Rev. Immunol. 17, 331 (1999); A. M. Chinnaiyan et al., Cell 81, 505 (1995); M. P. Boldin et al. J. Biol. Chem. 270, 7795 (1995); M. Muzio et al., Cell 85, 817 (1996); M. P. Boldin et al., Cell 85, 805 (1996); H. Hsu et al., Immunity 4, 387 (1996); H. Shu, M. Takeuchi, D. V. Goeddel, Proc. Natl. Acad. Sci. U.S.A. 93, 13973 (1996); A. T. Ting, F. X. Pimentel-Muinos, B. Seed, EMBO J. 15, 6189 (1996).
11. M. Lenardo et al., Annu. Rev. Immunol. 17, 221 (1999); D. Wallach et al., Annu. Rev. Immunol. 17, 331 (1999); A. M. Chinnaiyan et al., Cell 81, 505 (1995); M. P. Boldin et al. J. Biol. Chem. 270, 7795 (1995); M. Muzio et al., Cell 85, 817 (1996); M. P. Boldin et al., Cell 85, 805 (1996); H. Hsu et al., Immunity 4, 387 (1996); H. Shu, M. Takeuchi, D. V. Goeddel, Proc. Natl. Acad. Sci. U.S.A. 93, 13973 (1996); A. T. Ting, F. X. Pimentel-Muinos, B. Seed, EMBO J. 15, 6189 (1996).
12. M. Lenardo et al., Annu. Rev. Immunol. 17, 221 (1999); D. Wallach et al., Annu. Rev. Immunol. 17, 331 (1999); A. M. Chinnaiyan et al., Cell 81, 505 (1995); M. P. Boldin et al. J. Biol. Chem. 270, 7795 (1995); M. Muzio et al., Cell 85, 817 (1996); M. P. Boldin et al., Cell 85, 805 (1996); H. Hsu et al., Immunity 4, 387 (1996); H. Shu, M. Takeuchi, D. V. Goeddel, Proc. Natl. Acad. Sci. U.S.A. 93, 13973 (1996); A. T. Ting, F. X. Pimentel-Muinos, B. Seed, EMBO J. 15, 6189 (1996).
13. M. Lenardo et al., Annu. Rev. Immunol. 17, 221 (1999); D. Wallach et al., Annu. Rev. Immunol. 17, 331 (1999); A. M. Chinnaiyan et al., Cell 81, 505 (1995); M. P. Boldin et al. J. Biol. Chem. 270, 7795 (1995); M. Muzio et al., Cell 85, 817 (1996); M. P. Boldin et al., Cell 85, 805 (1996); H. Hsu et al., Immunity 4, 387 (1996); H. Shu, M. Takeuchi, D. V. Goeddel, Proc. Natl. Acad. Sci. U.S.A. 93, 13973 (1996); A. T. Ting, F. X. Pimentel-Muinos, B. Seed, EMBO J. 15, 6189 (1996).
14. M. Lenardo et al., Annu. Rev. Immunol. 17, 221 (1999); D. Wallach et al., Annu. Rev. Immunol. 17, 331 (1999); A. M. Chinnaiyan et al., Cell 81, 505 (1995); M. P. Boldin et al. J. Biol. Chem. 270, 7795 (1995); M. Muzio et al., Cell 85, 817 (1996); M. P. Boldin et al., Cell 85, 805 (1996); H. Hsu et al., Immunity 4, 387 (1996); H. Shu, M. Takeuchi, D. V. Goeddel, Proc. Natl. Acad. Sci. U.S.A. 93, 13973 (1996); A. T. Ting, F. X. Pimentel-Muinos, B. Seed, EMBO J. 15, 6189 (1996).
15. M. Lenardo et al., Annu. Rev. Immunol. 17, 221 (1999); D. Wallach et al., Annu. Rev. Immunol. 17, 331 (1999); A. M. Chinnaiyan et al., Cell 81, 505 (1995); M. P. Boldin et al. J. Biol. Chem. 270, 7795 (1995); M. Muzio et al., Cell 85, 817 (1996); M. P. Boldin et al., Cell 85, 805 (1996); H. Hsu et al., Immunity 4, 387 (1996); H. Shu, M. Takeuchi, D. V. Goeddel, Proc. Natl. Acad. Sci. U.S.A. 93, 13973 (1996); A. T. Ting, F. X. Pimentel-Muinos, B. Seed, EMBO J. 15, 6189 (1996).
16. Y. Jiang et al., Science 283, 543 (1999).
17. D. Banner et al.,. Cell 73, 431 (1993).
18. L. Tartaglia and D. Goeddel, J. Biol. Chem. 267, 4304 (1992); H. Loetscher et al., J. Biol. Chem. 266, 18324 (1991); C. A. Smith, T. Farrah, R. C. Goodwin, Cell 76, 959 (1994).
19. L. Tartaglia and D. Goeddel, J. Biol. Chem. 267, 4304 (1992); H. Loetscher et al., J. Biol. Chem. 266, 18324 (1991); C. A. Smith, T. Farrah, R. C. Goodwin, Cell 76, 959 (1994).
20. L. Tartaglia and D. Goeddel, J. Biol. Chem. 267, 4304 (1992); H. Loetscher et al., J. Biol. Chem. 266, 18324 (1991); C. A. Smith, T. Farrah, R. C. Goodwin, Cell 76, 959 (1994).
21. H9 lymphoma cells were washed and resuspended in phosphate-buffered saline. The cells were then incubated with human recombinant TNF-α (100 ng/ml) (R&D Systems) for 1 hour at 4°C with rotation. Cells were then treated with a 2 mM solution of the cross-linker DTSSP (Pierce) for 30 min, and the reaction was quenched with 20 mM tris-Cl (pH 7.5) for 15 min on ice. The cells were lysed in 150 mM NaCl, 20 mM tris-Cl (pH 7.5), 1 mM EDTA, 30 mM NaF, 2 mM β-glycerophosphate, and 1 mM sodium orthovanadate with protease inhibitors added (Boehringer-Mannheim). Equal amounts of the lysates were subjected to electrophoresis under nonreducing (without β-mercaptoethanol) or reducing (with 280 mM β-mercaptoethanol) conditions and were analyzed for p60 and p80 complexes with specific anti-bodies (Santa Cruz). Densitometry was performed with a Kodak Image Station 440. Results shown are representative of three independent experiments.
22. S. J. Jones et al., J. Immunol. 162, 1042 (1999).
23. Western blot analysis confirmed the absence of TNF-α in the lysates. Immunoprecipitation of the cross-linked complexes with antibody to p60 revealed no detectable level of p80 in the p60 complex in Western blots.
24. M. Boldin et al., J. Biol. Chem. 270, 387 (1995).
25. L. Zheng and M. J. Lenardo, unpublished data.
26. 2-terminus of the receptors. The PCR product was digested with Bam HI and Eco RI and cloned into pcDNA3. The PCR fragments containing the receptor fragments were then introduced into this plasmid using the Eco RI and Xho I sites. For the GFP/CFP/YFP chimeras, the fragments were amplified by PCR and introduced in-frame into the Xho I and Xba I sites of p60ΔCD-HA. 293T cells were transfected with Fugene 6 (Boehringer-Mannheim) as per the manufacturer's protocol. Cells were lysed in 150 mM NaCl, 20 mM tris-Cl (pH 7.5), 1 mM EDTA, 30 mM NaF, 2 mM β-glycerophosphate, 1 mM sodium orthovanadate, 5 mM iodoacetamide, 2 mM dithiothreitol, 1% Triton X-100, and protease inhibitors (Boehringer-Mannheim). After preclearing with protein G agarose beads (Boehringer-Mannheim) and normal mouse immunoglobulin G (IgG), proteins were immunoprecipitated from the lysates with 2 μg of anti-GFP and protein G agarose beads. Immune complexes were washed twice with lysis buffer containing 0.5 M NaCl and then three times with regular lysis buffer. Immune complexes were resolved on Tris/Glycine gels (Novex, San Diego, CA). Results shown are representative of five independent experiments. Transfection in Jurkat cells showed similar results.
27. F. K. M. Chan and M. J. Lenardo, unpublished data.
28. S. A. Marster et al., J. Biol. Chem. 267, 5747 (1992); K. C. Hsu and M. V. Chao, J. Biol. Chem. 268, 16430 (1993); P. C. Chen, G. C. DuBois, M. Chen, J. Biol. Chem. 270, 2874 (1995); T. Reid, P. Louie, R. A. Heller, Circ. Shock 44, 84 (1994); A. E. Corcoran et al., Eur. J. Biochem. 223, 831 (1994).
29. S. A. Marster et al., J. Biol. Chem. 267, 5747 (1992); K. C. Hsu and M. V. Chao, J. Biol. Chem. 268, 16430 (1993); P. C. Chen, G. C. DuBois, M. Chen, J. Biol. Chem. 270, 2874 (1995); T. Reid, P. Louie, R. A. Heller, Circ. Shock 44, 84 (1994); A. E. Corcoran et al., Eur. J. Biochem. 223, 831 (1994).
30. S. A. Marster et al., J. Biol. Chem. 267, 5747 (1992); K. C. Hsu and M. V. Chao, J. Biol. Chem. 268, 16430 (1993); P. C. Chen, G. C. DuBois, M. Chen, J. Biol. Chem. 270, 2874 (1995); T. Reid, P. Louie, R. A. Heller, Circ. Shock 44, 84 (1994); A. E. Corcoran et al., Eur. J. Biochem. 223, 831 (1994).
31. S. A. Marster et al., J. Biol. Chem. 267, 5747 (1992); K. C. Hsu and M. V. Chao, J. Biol. Chem. 268, 16430 (1993); P. C. Chen, G. C. DuBois, M. Chen, J. Biol. Chem. 270, 2874 (1995); T. Reid, P. Louie, R. A. Heller, Circ. Shock 44, 84 (1994); A. E. Corcoran et al., Eur. J. Biochem. 223, 831 (1994).
32. S. A. Marster et al., J. Biol. Chem. 267, 5747 (1992); K. C. Hsu and M. V. Chao, J. Biol. Chem. 268, 16430 (1993); P. C. Chen, G. C. DuBois, M. Chen, J. Biol. Chem. 270, 2874 (1995); T. Reid, P. Louie, R. A. Heller, Circ. Shock 44, 84 (1994); A. E. Corcoran et al., Eur. J. Biochem. 223, 831 (1994).
33. Mutagenesis was performed with the Quikchange method (Stratagene) as per the manufacturer's instructions. The mutations were confirmed by DNA sequencing.
34. Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
35. L. Tron et al., Biophys. J. 45, 939 (1984); J. Szollosi et al., Cytometry 5, 210 (1984).
36. L. Tron et al., Biophys. J. 45, 939 (1984); J. Szollosi et al., Cytometry 5, 210 (1984).
37. R. Y. Tsien, Annu. Rev. Biochem. 67, 509 (1998).
38. R. M. Siegel et al., Science 288, 2354 (2000); R. M. Siegel et al., "Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein," Science's STKE (2000) (www.stke.org/cgi/content/full/OC_sigtrans;2000/38/pl1).
39. R. M. Siegel et al., Science 288, 2354 (2000); R. M. Siegel et al., "Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein," Science's STKE (2000) (www.stke.org/cgi/content/full/OC_sigtrans;2000/38/pl1).
40. G. Papoff et al., J. Biol. Chem. 274, 38241 (1999).
41. J. Naismith et al., J. Biol. Chem. 270, 13303 (1995); J. Naismith et al., Structure 4, 1251 (1996); J. Naismith et al., J. Mol. Recog. 9, 113 (1995).
42. J. Naismith et al., J. Biol. Chem. 270, 13303 (1995); J. Naismith et al., Structure 4, 1251 (1996); J. Naismith et al., J. Mol. Recog. 9, 113 (1995).
43. J. Naismith et al., J. Biol. Chem. 270, 13303 (1995); J. Naismith et al., Structure 4, 1251 (1996); J. Naismith et al., J. Mol. Recog. 9, 113 (1995).
44. F. K.-M. Chan and M. J. Lenardo, Eur. J. Immunol. 30, 652 (2000).
45. R. A. Heller et al., Cell 70, 47 (1992); T. Weiss et al, J. Immunol. 158, 2398 (1997); V. Haridas et al., J. Immunol. 160, 3152 (1998); W. Declercq et al., J. Immunol. 161, 390 (1998).
46. R. A. Heller et al., Cell 70, 47 (1992); T. Weiss et al, J. Immunol. 158, 2398 (1997); V. Haridas et al., J. Immunol. 160, 3152 (1998); W. Declercq et al., J. Immunol. 161, 390 (1998).
47. R. A. Heller et al., Cell 70, 47 (1992); T. Weiss et al, J. Immunol. 158, 2398 (1997); V. Haridas et al., J. Immunol. 160, 3152 (1998); W. Declercq et al., J. Immunol. 161, 390 (1998).
48. R. A. Heller et al., Cell 70, 47 (1992); T. Weiss et al, J. Immunol. 158, 2398 (1997); V. Haridas et al., J. Immunol. 160, 3152 (1998); W. Declercq et al., J. Immunol. 161, 390 (1998).
49. C. Guo, S. K. Dower, D. Howlowka, B. Baird, J. Biol. Chem. 270, 27562 (1995); S. Damjanovich et al., Proc. Natl. Acad. Sci. U.S.A. 93, 13973 (1996); T. Gadella Jr. and T. M. Jovin, J. Cell. Biol. 129, 1543 (1995).
50. C. Guo, S. K. Dower, D. Howlowka, B. Baird, J. Biol. Chem. 270, 27562 (1995); S. Damjanovich et al., Proc. Natl. Acad. Sci. U.S.A. 93, 13973 (1996); T. Gadella Jr. and T. M. Jovin, J. Cell. Biol. 129, 1543 (1995).
51. C. Guo, S. K. Dower, D. Howlowka, B. Baird, J. Biol. Chem. 270, 27562 (1995); S. Damjanovich et al., Proc. Natl. Acad. Sci. U.S.A. 93, 13973 (1996); T. Gadella Jr. and T. M. Jovin, J. Cell. Biol. 129, 1543 (1995).
52. O. Livnah et al., Science 283, 987 (1999); I. Remy, I. A. Wilson, S. W. Michnick, Science 283, 990 (1999).
53. O. Livnah et al., Science 283, 987 (1999); I. Remy, I. A. Wilson, S. W. Michnick, Science 283, 990 (1999).
54. Receptor expression was monitored by staining with monoclonal antibodies to HA and p80 (clone MAB226, R&D Systems). TNF-α binding was determined with biotinylated TNF-α (NEN Life Sciences) and a secondary fluorescein-conjugated streptavidin label. Samples were analyzed on a FACScan flow cytometer. Results shown are representative of at least five experiments.
55. Fifteen micrograms of the corresponding plasmids were transfected into p80 Jurkat cells (22) by electroporation using a BTX Electro Cell Manipulator 600. After 9 to 24 hours, cells were stimulated with the indicated amount of TNF-α for 12 to 16 hours. Cells were then stained for HA expression and propidium iodide uptake. The number of HA-positive cells was scored under constant time, and percent inhibition of apoptosis was calculated by normalizing to the percentage of cell death induced in the HveAΔCD-HA-transfected samples. Results are representative of three experiments.
56. We thank P. Scheurich, P. Spear, A. Winoto, and J. Woronicz for providing us with antibodies and plasmids; L. D'Adamio, R. Germain, W. Leonard, D. Levens, H. Metzger, J. O'Shea, W. Paul, and T. Waldmann for critical reading of the manuscript; K. Holmes, R. Swofford, and D. Stephany for help with the fluorescence energy transfer studies; M. Boguski for bioinformatics assistance; and the members of the Lenardo lab for discussion. F.K.-M.C. is supported by a Cancer Research Institute/Miriam and Benedict Wolf fellowship. H.J.C. is a Howard Hughes Medical Institute/National Institutes of Health research scholar.